Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FlutiForm versus fluticasone plus formoterol in persistent reversible asthma
2007-001634-13Phase 3Completed
- Sponsor
- Mundipharma
- Start
- Jul 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in asthma comparing FlutiForm pMDI with Fluticasone pMDI plus formoterol DPI (2 arms). Primary endpoint: Post-morning dose mean FEV1 during treatment. Started Jul 2007; status: completed.
02
Drugs
fluticasone propionate + formoterolfluticasone propionateformoterol
03
Conditions
asthma
Beyond the preview
Go deeper on 2007-001634-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001634-13.